New Biomarker May Improve Diagnosis of Rare Brain and Eye Cancers
The study identifies HAVCR1 as a tool for earlier detection and treatment monitoring for primary central nervous system lymphoma.
Category: Lymphoma
Lymphoma
Latest
Lymphoma
Latest
New Test Predicts Lymphoma Patient Treatment Outcomes
Researchers discovered a way to predict whether a cancer of the immune system will recur in patients treated with a bone marrow transplant.
Lymphoma
Latest
Foresight Diagnostics Shares Vision of Lymphoma MRD Detection
Foresight's first commercially available test offering will be a CLIA-validated B-cell lymphoma MRD assay.
Cytek Biosciences Debuts Advanced Five-Laser Flow Cytometer
The Aurora system is now available with five lasers, making it possible for researchers to visualize more than 30 colors from a single sample.
Read More
Immunohistochemistry Test Detects ROS1 Protein in Cancer
The biomarker may provide a cost-effective and efficient means to identify elevated ROS1 protein expression in cancer.
Read More
From the Editor: New Ideas
In a field where highly trained professionals interact on a daily basis with an ever-changing array of innovative technologies, new and useful ideas seem to be around every corner.
Read More
Clinical Flow Cytometry System Improves Workflow
New 10-color system with Kaluza C software streamlines workflow and QC reporting for flow cytometry in leukemia and lymphoma analysis.
Read More
January 2019 Product Spotlight: 2019 Emerging Technologies Showcase
Nano-Signature Discovery Could Revolutionize Cancer Diagnosis A quick and easy test to...
Read More
Study Results Guide Anti-CMV Treatment after Stem Cell Transplantation
Continued validation of Lophius’ development capabilities bodes well as the company advances into tuberculosis diagnostics as its next focus area.
Read More
Nano-Signature Discovery Could Revolutionize Cancer Diagnosis
The new technology has proved to be up to 90% accurate in tests involving 200 human cancer samples and normal DNA.
Read More
Determining Molecular Response in Chronic Myeloid Leukemia
Droplet digital PCR can provide a more accurate assessment of low levels of BCR-ABL mRNA than quantitative real-time PCR.
Read More
ASCP, ASH, and CAP Invite Public Comment on Lymphoma Guideline
Multidisciplinary guidance document focuses on specimen requirements for the diagnosis of lymphoma.
Read More
August/September 2017 Product Spotlight: New Products Showcase
This month’s Product Spotlight features new products from such companies as Advanced Instruments, Beckman Coulter, and Thermo Fisher Scientific.
Read More
HTG Molecular Diagnostics Launches NGS-Based Cell-of-Origin Assay for Diffuse Large B-Cell Lymphomas
HTG’s next-generation sequencing assay enables subtyping of DLBCL as activated B-cell-like or germinal center B-cell-like.
Read More
NCI Awards $1.4 Million Grant to Advanced Cell Diagnostics
Under a new grant from the National Cancer Institute, Advanced Cell Diagnostics will partner with the Cleveland Clinic to develop an ultrasensitive diagnostic test for B-cell lymphoma.
Read MorePathGroup Collaboration to Offer Genomic Profiling of Hematologic Malignancies
A new collaboration plans to provide genomic profiling and information for patients that have been unsuccessful on repeated therapy for the group of cancers that include leukemias, lymphomas, and myeloproliferative and myelodysplastic diseases.
Read MoreTool Could Help Assessment of Hodgkin’s Lymphoma and Breast Cancer
A new study shows the MultiOmyx profile could improve disease assessment for both diseases using multiplex proteins.
Read More
Sequenta Expands Sample Types Accepted for ClonoSIGHT MRD Test for Leukemia, Lymphoma
Ultra-sensitive detection of minimal residual disease now available to more people with blood cancers.
Read More